R. Kaas

625 total citations
12 papers, 344 citations indexed

About

R. Kaas is a scholar working on Genetics, Cancer Research and Oncology. According to data from OpenAlex, R. Kaas has authored 12 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in R. Kaas's work include BRCA gene mutations in cancer (9 papers), Global Cancer Incidence and Screening (4 papers) and Breast Cancer Treatment Studies (3 papers). R. Kaas is often cited by papers focused on BRCA gene mutations in cancer (9 papers), Global Cancer Incidence and Screening (4 papers) and Breast Cancer Treatment Studies (3 papers). R. Kaas collaborates with scholars based in Netherlands and United Kingdom. R. Kaas's co-authors include F.A.N. Zoetmulder, Emiel J. Rutgers, A. A. M. Hart, Hester S. A. Oldenburg, A.P.E. Besnard, Jelle Wesseling, Senno Verhoef, Matti A. Rookus, Marie‐Jeanne Vrancken Peeters and Sara Müller and has published in prestigious journals such as Annals of Surgery, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

R. Kaas

12 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Kaas Netherlands 9 145 130 116 83 59 12 344
Daymen S. Tuscano United States 8 92 0.6× 52 0.4× 75 0.6× 94 1.1× 77 1.3× 10 283
Carlie K. Thompson United States 10 126 0.9× 107 0.8× 219 1.9× 245 3.0× 76 1.3× 18 472
Rodrigo Santa Cruz Guindalini Brazil 11 51 0.4× 101 0.8× 86 0.7× 100 1.2× 57 1.0× 28 284
Rebecca B. Schechter United States 5 153 1.1× 94 0.7× 34 0.3× 102 1.2× 25 0.4× 9 451
Bruna Salani Mota Brazil 8 116 0.8× 26 0.2× 153 1.3× 110 1.3× 63 1.1× 20 302
Tomasz Czechura United States 9 318 2.2× 213 1.6× 430 3.7× 149 1.8× 145 2.5× 10 574
B.A.M. Heemskerk-Gerritsen Netherlands 8 51 0.4× 331 2.5× 191 1.6× 125 1.5× 49 0.8× 13 440
Kamilla Krawiec Sweden 8 119 0.8× 40 0.3× 128 1.1× 149 1.8× 26 0.4× 10 340
Hong-Jian Yang China 8 38 0.3× 68 0.5× 187 1.6× 285 3.4× 79 1.3× 11 447
Rebecca Doherty United Kingdom 8 42 0.3× 182 1.4× 72 0.6× 71 0.9× 45 0.8× 28 345

Countries citing papers authored by R. Kaas

Since Specialization
Citations

This map shows the geographic impact of R. Kaas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Kaas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Kaas more than expected).

Fields of papers citing papers by R. Kaas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Kaas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Kaas. The network helps show where R. Kaas may publish in the future.

Co-authorship network of co-authors of R. Kaas

This figure shows the co-authorship network connecting the top 25 collaborators of R. Kaas. A scholar is included among the top collaborators of R. Kaas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Kaas. R. Kaas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Tilanus‐Linthorst, Madeleine M.A., Hester F. Lingsma, D. Gareth Evans, et al.. (2013). Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer risk. International Journal of Cancer. 133(1). 156–163. 18 indexed citations
2.
Tilanus‐Linthorst, Madeleine M.A., Hester F. Lingsma, D. Gareth Evans, et al.. (2012). 150 Optimal Age to Start Preventive Measures in Women with BRCA1/2 Mutations or High Familial Breast Cancer Risk. European Journal of Cancer. 48. S83–S84. 1 indexed citations
3.
Kaas, R., Senno Verhoef, Jelle Wesseling, et al.. (2010). Prophylactic Mastectomy in BRCA1 and BRCA2 Mutation Carriers. Annals of Surgery. 251(3). 488–492. 63 indexed citations
4.
Kaas, R., Senno Verhoef, Hester S. A. Oldenburg, et al.. (2008). Very low risk for subsequent breast cancer in BRCA1/2 carriers after prophylactic mastectomy. European Journal of Cancer Supplements. 6(7). 91–91. 2 indexed citations
5.
Kaas, R., Sara Müller, A. A. M. Hart, & Emiel J. Rutgers. (2007). Stage of breast cancers found during the surveillance of women with a familial or hereditary risk. European Journal of Surgical Oncology. 34(5). 501–507. 9 indexed citations
6.
Kaas, R., Robert Kröger, Johannes L. Peterse, A. A. M. Hart, & Sara Müller. (2006). The correlation of mammographic-and histologic patterns of breast cancers in BRCA1 gene mutation carriers, compared to age-matched sporadic controls. European Radiology. 16(12). 2842–2848. 14 indexed citations
7.
Kaas, R., A. A. M. Hart, & Emiel J. Rutgers. (2005). The impact of the physician on the accrual to randomized clinical trials in patients with primary operable breast cancer. The Breast. 14(4). 310–316. 19 indexed citations
8.
Kaas, R., Robert Kröger, Jan H. C. L. Hendriks, et al.. (2004). The significance of circumscribed malignant mammographic masses in the surveillance of BRCA 1/2 gene mutation carriers. European Radiology. 14(9). 1647–53. 32 indexed citations
9.
Kaas, R., J.L. Peterse, A. A. M. Hart, et al.. (2003). The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer. British Journal of Cancer. 88(5). 707–710. 8 indexed citations
10.
Kaas, R., et al.. (2001). Chylous ascites after oncological abdominal surgery: incidence and treatment. European Journal of Surgical Oncology. 27(2). 187–189. 122 indexed citations
11.
Kaas, R., A. A. M. Hart, A.P.E. Besnard, Johannes L. Peterse, & Emiel J. Rutgers. (2001). Impact of mammographic interval on stage and survival after the diagnosis of contralateral breast cancer. British journal of surgery. 88(1). 123–127. 25 indexed citations
12.
Kaas, R., et al.. (1998). Breast carcinoma in residual breast tissue after prophylactic bilateral subcutaneous mastectomy. European Journal of Surgical Oncology. 24(4). 331–332. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026